Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BACKGROUND: Chemotherapy is the standard adjuvant treatment for colon cancer. Chinese herbal formula PRM1201 improves the efficacy of chemotherapy when used in combination with Cetuximab or Bevacizumab in patients with metastatic colorectal cancer. This study aims to explore the benefits of treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ru, Liu, Ningning, Cai, Guoxiang, Zhang, Yun, Xiao, Haijuan, Zhou, Lihong, Ji, Qing, Zhao, Ling, Zeng, Puhua, Liu, Huaimin, Huo, Jiege, Yue, Xiaoqiang, Zhang, Yi, Wu, Chaojun, Sun, Xiaoting, Feng, Yuanyuan, Liu, Hongjie, Liu, Hui, Han, Zhifen, Lai, Youying, Zhang, Yanbo, Han, Gang, Gong, Hangjun, Wang, Yan, Li, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968418/
https://www.ncbi.nlm.nih.gov/pubmed/33747930
http://dx.doi.org/10.3389/fonc.2021.618793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968418/
https://www.ncbi.nlm.nih.gov/pubmed/33747930
http://dx.doi.org/10.3389/fonc.2021.618793

Ejemplares similares